Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.405 USD | -2.15% | -6.51% | -14.76% |
May. 24 | Recursion Names HilleVax CEO Robert Hershberg as New Board Chair | MT |
May. 24 | Recursion Pharmaceuticals, Inc. Announces Chair of the Board Changes | CI |
Financials (USD)
Sales 2024 * | 58.86M | Sales 2025 * | 63.02M | Capitalization | 2B |
---|---|---|---|---|---|
Net income 2024 * | -401M | Net income 2025 * | -472M | EV / Sales 2024 * | 27.9 x |
Net cash position 2024 * | 358M | Net cash position 2025 * | 336M | EV / Sales 2025 * | 26.4 x |
P/E ratio 2024 * |
-5.12
x | P/E ratio 2025 * |
-4.62
x | Employees | 500 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.87% |
1 day | -2.15% | ||
1 week | -6.51% | ||
Current month | +1.51% | ||
1 month | -4.92% | ||
3 months | -31.67% | ||
6 months | +13.43% | ||
Current year | -14.76% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 41 | 13-11-04 | |
Blake Borgeson
FOU | Founder | 42 | 13-11-04 |
Dean Li
FOU | Founder | 62 | 13-11-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Hershberg
BRD | Director/Board Member | 61 | 20-03-19 |
Dean Li
FOU | Founder | 62 | 13-11-04 |
Blake Borgeson
FOU | Founder | 42 | 13-11-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.51% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 8.41 | -2.10% | 2,975,443 |
24-06-03 | 8.59 | +3.74% | 4,637,922 |
24-05-31 | 8.28 | -6.65% | 6,518,092 |
24-05-30 | 8.87 | +3.38% | 3,384,268 |
24-05-29 | 8.58 | -4.56% | 5,740,988 |
Delayed Quote Nasdaq, June 04, 2024 at 03:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.76% | 2.04B | |
+16.73% | 121B | |
+13.04% | 107B | |
-5.80% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.00% | 15.31B | |
+1.18% | 14.08B | |
+24.18% | 11.74B |
- Stock Market
- Equities
- RXRX Stock